Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care
Susan Olender(Columbia University Irving Medical Center), Lindsey Smith(Gilead Sciences (United States)), Holly Edgar(Gilead Sciences (United Kingdom)), José Ignacio Bernardino(Hospital Universitario La Paz), Robert Gottlieb(Baylor University Medical Center), Anu Osinusi(Gilead Sciences (United States)), Bindu Balani(Association Clinique et Thérapeutique Infantile du Val de Marne), Tak Yin Owen Tsang(Kwai Chung Hospital), Richard Haubrich(University of California San Diego), Philip A. Robinson(Hoag Memorial Hospital Presbyterian), Àlex Soriano(Instituto de Salud Carlos III), Alan S. Go(Kaiser Permanente), Anand P. Chokkalingam(Berkeley Public Health Division), Nirav Shah(NorthShore University HealthSystem), Shobha Swaminathan(Rutgers, The State University of New Jersey), Robertino M. Mera(Center for HIV and Hepatogastroenterology), Joel E. Gallant(Johns Hopkins University), Helena Díaz-Cuervo(Gilead Sciences (Spain)), Lanjia Lin(Gilead Sciences (United States)), B Nebiyou Bekele(Gilead Sciences (United States)), I‐Heng Lee(Gilead Sciences (United States)), Jihad Slim(Saint Michael's Medical Center), Hao Hu(Xi'an University of Architecture and Technology), Eboni G. Price‐Haywood(Ochsner Health System), Theresa L. Walunas(Northwestern University), Su Wang(Rutgers, The State University of New Jersey), Lijie Zhong(Gilead Sciences (United States)), Katherine K Perez(Houston Methodist), Chloé Phulpin(Gilead Sciences (United Kingdom)), Diana M. Brainard(Gilead Sciences (United States))
Cited by 171
Related Papers
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
|New England Journal of Medicine|2004|11.4k
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Prevalence of Diagnosed Atrial Fibrillation in Adults
|JAMA|2001|6.2k
Heart Disease and Stroke Statistics—2013 Update
|Circulation|2012|5.2k